A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation.
Andre Russowsky Brunoni, Joao Amadera, Bruna Berbel...
https://pubmed.ncbi.nlm.nih.gov/21320389/Actively Recruiting
Led by Beth Israel Deaconess Medical Center · Updated on 2026-03-04
24
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating ways to help adults with visual field deficits caused by damage to the primary visual cortex, often due to stroke. This study aims to develop and improve a rehabilitation program using visual training combined with noninvasive brain stimulation to promote recovery of vision in the affected blind areas. The trial involves participants with different types of strokes and will assess improvements in visual abilities using standard visual field tests and motion discrimination tasks. Participants will be assigned to one of several groups receiving different interventions visual training with transcranial random noise stimulation tRNS, sham stimulation with visual training, tRNS alone without training, sham stimulation without training, or visual training using virtual reality combined with tRNS. Treatments involve daily 20 to 30-minute sessions over two weeks, where brain stimulation is delivered via electrodes placed on the scalp over the visual cortex, while participants perform visual motion tasks on a computer or in a VR headset. Throughout the study, participants will undergo assessments including visual field tests, questionnaires to measure quality of life, and electrophysiological recordings to monitor neural responses. Safety and side effects will be closely monitored daily during sessions, with a licensed physician available for any concerns. The study includes follow-up evaluations up to six months after treatment to measure lasting effects. Participants will be tracked and supported to complete scheduled visits and assessments over the study period.
CONDITIONS
Improving Visual Field Deficits With Noninvasive Brain Stimulation
L
Lorella Battelli, PhD
M
Meghna Uzgare, BS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Beth Israel Deaconess Medical Center
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Noninvasive Brain Stimulation plus Visual Training | Sham Stimulation Only |
|---|---|---|
| What it is | A program where participants with partial visual field loss after stroke receive noninvasive brain stimulation (tRNS) at the visual cortex together with targeted visual training activities using either a computer or virtual reality setup. | A control approach where participants receive sham (inactive) brain stimulation and do not participate in any computer-based or virtual reality-based visual training exercises. |
| Role in trial | Investigational treatment arm evaluating whether brain stimulation combined with active visual training improves visual motion discrimination and functional vision. | Control arm to account for placebo and non-specific effects, providing sham stimulation without active visual training. |
| Primary intended use | To test whether pairing tRNS and repeated visual field training can improve visual discrimination and potentially daily function in people with post-stroke cortical blindness. | To serve as a comparison for effects of the active intervention, helping to discriminate real effects from placebo or natural recovery. |
| How it is provided | Participants are fitted with scalp electrodes for 20–30 minute sessions of tRNS while completing visual training tasks on a screen or via a VR headset, repeated on 10 weekdays over 2 weeks. | Participants receive identical electrode setup with a brief initial current ramp, but otherwise no stimulation is given, and no visual training is performed. |
| Evidence status | Early studies suggest that noninvasive brain stimulation can enhance the effects of visual training, but large-scale trials are needed to confirm consistent benefit in stroke-related visual field loss. | No improvement in visual field function is expected, as sham stimulation with no training is designed to account for placebo effects and natural history. |
| Important risks | Noninvasive brain stimulation is generally well tolerated, but mild side effects such as skin tingling or discomfort, headache, or fatigue can occur. Severe adverse effects are rare when appropriate exclusion criteria are followed. | Sham stimulation generally has minimal risk. Minor discomfort related to scalp electrodes or brief stimulation sensations may occur. |
| Important limitations | Additional research is needed to determine if visual improvements observed in early studies and small trials are sustained in larger, more diverse stroke populations. Individual variability in brain structure and timing since stroke can impact outcomes. | As a control, participants do not receive active training or stimulation; thus, there is no expectation of visual or functional improvement. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for consent and eligibility assessment
Duration - 2 weeks (10 consecutive weekdays)
Participants undergo 10 daily sessions of 20 to 30 minutes each of noninvasive brain stimulation (tRNS or sham) with or without visual training using computer or virtual reality tasks to improve visual perception after stroke.
10 daily visits (in-person) for stimulation and/or visual training
Duration - Up to 6 months after treatment
Participants are monitored for changes in visual function and quality of life after treatment, including assessments at 6 months post-training.
At least 1 follow-up visit after treatment completion
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Andre Russowsky Brunoni, Joao Amadera, Bruna Berbel...
https://pubmed.ncbi.nlm.nih.gov/21320389/A Antal, I Alekseichuk, M Bikson...
https://pubmed.ncbi.nlm.nih.gov/28709880/Matteo Feurra, Patrizio Pasqualetti, Giovanni Bianco...
https://pubmed.ncbi.nlm.nih.gov/24174681/V P Clark, J M Maisog, J V Haxby
https://pubmed.ncbi.nlm.nih.gov/9636124/M L Dombovy, B A Sandok, J R Basford
https://pubmed.ncbi.nlm.nih.gov/2940735/Anasuya Das, Margaret Demagistris, Krystel R Huxlin
https://pubmed.ncbi.nlm.nih.gov/22514305/Voyko Kavcic, Regina L Triplett, Anasuya Das...
https://pubmed.ncbi.nlm.nih.gov/25575450/Michael A Nitsche, Walter Paulus
https://pubmed.ncbi.nlm.nih.gov/22085959/Krystel R Huxlin, Tim Martin, Kristin Kelly...
https://pubmed.ncbi.nlm.nih.gov/19339594/Jonas Larsson, David J Heeger
https://pubmed.ncbi.nlm.nih.gov/17182764/Beth Israel Deaconess Medical Center
Lead Sponsor